fda compounding semaglutide enforcement november 2025 Have patients been harmed by unsafe drug compounding? – Partnership for Safe Medicines Novo Nordisk expands legal action

While modafinil itself has been studied extensively and approved for specific medical uses, its analogues have not

Doctor-trusted medications Medvi only prescribes medication that has been tested for quality and safety

Tirzepatide is a dual GIP/GLP-1 receptor agonist (the active ingredient in Zepbound and Mounjaro)

The recent December 2025 phase 3 trial showed even better results

In the UK, the Medicines and Healthcare products Regulatory Agency (MHRA) has licensed specific GLP-1 medications for use only in people who are obese, overweight with related health problems, or have type 2 diabetes

Micronized progesterone is generally preferred over synthetic progestins due to a more favorable cardiovascular and neurocognitive profile